Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.

Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R; French Infectious Diseases Society (French acronym SPILF), the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), and the SPA2 group.

Med Mal Infect. 2015 Nov-Dec;45(11-12):475-80. doi: 10.1016/j.medmal.2015.10.001. Epub 2015 Nov 21.

PMID:
26612602
2.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

3.

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.

Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T, Gueit I, Mortier E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortalité 2010 and GERMIVIC study groups.

HIV Med. 2015 Apr;16(4):230-9. doi: 10.1111/hiv.12204. Epub 2014 Dec 18.

PMID:
25522874
4.

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.

Michot JM, Driss F, Guitton C, Moh Klaren J, Lefebvre F, Chamillard X, Gallon P, Fourn E, Pela AM, Tertian G, Le Bras P, Chantalat-Auger C, Delfraissy JF, Goujard C, Lambotte O.

Transfusion. 2015 Feb;55(2):357-63. doi: 10.1111/trf.12875. Epub 2014 Sep 23.

PMID:
25251746
5.

[Disseminated varicella-zoster virus infection with hemorrhagic gastritis during the course of chronic lymphocytic leukemia: case report and literature review].

Serris A, Michot JM, Fourn E, Le Bras P, Dollat M, Hirsch G, Pallier C, Carbonnel F, Tertian G, Lambotte O.

Rev Med Interne. 2014 May;35(5):337-40. doi: 10.1016/j.revmed.2013.05.004. Epub 2013 Jun 14. Review. French.

PMID:
23773904
6.

Treatment of limbic encephalitis with anti-glioma-inactivated 1 (LGI1) antibodies.

Krastinova E, Vigneron M, Le Bras P, Gasnault J, Goujard C.

J Clin Neurosci. 2012 Nov;19(11):1580-2. doi: 10.1016/j.jocn.2011.12.025. Epub 2012 Aug 25.

PMID:
22925419
7.

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, de Wolf F, Bucher HC, Elzi L, Touloumi G, Vourli G, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Abgrall S, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration.

AIDS. 2012 Aug 24;26(13):1691-705.

8.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration.

Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28.

9.

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

HIV-CAUSAL Collaboration, Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA.

Ann Intern Med. 2011 Apr 19;154(8):509-15. doi: 10.7326/0003-4819-154-8-201104190-00001.

10.

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.

Piroth L, Pol S, Lacombe K, Miailhes P, Rami A, Rey D, Loustau-Ratti V, Morlat P, Goderel I, Sene D, Rosenthal E, Carrat F, Cacoub P; GERMIVIC Study Group.

J Hepatol. 2010 Dec;53(6):1006-12. doi: 10.1016/j.jhep.2010.04.041. Epub 2010 Aug 4.

PMID:
20800920
11.

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

HIV-CAUSAL Collaboration, Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA.

AIDS. 2010 Jan 2;24(1):123-37. doi: 10.1097/QAD.0b013e3283324283.

12.

[Cat scratch disease with bone involvement: a case report and literature review].

Roubaud-Baudron C, Fortineau N, Goujard C, Le Bras P, Lambotte O.

Rev Med Interne. 2009 Jul;30(7):602-8. doi: 10.1016/j.revmed.2009.01.015. Epub 2009 Mar 19. Review. French.

PMID:
19303175
13.

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortavic/Mortalité 2005 Study Group.

HIV Med. 2009 May;10(5):282-9. doi: 10.1111/j.1468-1293.2008.00686.x. Epub 2009 Feb 15.

14.

Acquired hemophilia in older people: a poor prognosis despite intensive care.

Lambotte O, Dautremer J, Guillet B, Boutekedjiret T, Dreyfus M, Kotb R, Le Bras P, Delfraissy JF, Lambert T, Goujard C.

J Am Geriatr Soc. 2007 Oct;55(10):1682-5. No abstract available.

PMID:
17908073
15.

[Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir].

Harmouche H, Le Bras P, Bignani O, Delfraissy JF, Goujard C.

Rev Med Interne. 2005 Jun;26(6):522-3. Epub 2005 Mar 16. French. No abstract available.

PMID:
15936484
16.

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV.

Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D.

AIDS. 2004 Oct 21;18(15):2029-38.

PMID:
15577624
18.

Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia.

Venencie PY, Le Bras P, Toan ND, Tchernia G, Delfraissy JF.

J Am Acad Dermatol. 1995 Apr;32(4):666-7. No abstract available.

PMID:
7896960
19.

Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?

Le Bras P, D'Oiron R, Quertainmont Y, Halfon P, Caquet R.

AIDS. 1994 May;8(5):716-7. No abstract available.

PMID:
8060560
20.

Standardization of heparin therapy improves efficacy.

Le Bras P, Halfon P.

Arch Intern Med. 1992 Oct;152(10):2140, 2143. No abstract available.

PMID:
1417390
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk